| 2025 | | Deferoxamine prevents dexamethasone-induced muscle atrophy by reducing MuRF1 and atrogin-1
Frontiers in pharmacology, 16. : 1582216-1582216, 2025 | 김혜진, 이관우, 이나미, 전자영, 최성이, 최재명, 한승진, 허유정 |
| 2025 | | Empagliflozin Alleviates Hepatic Steatosis and Oxidative Stress via the NRF1 Pathway in High-Fat Diet-Induced Mouse Model of Metabolic Dysfunction-Associated Steatotic Liver Disease
International journal of molecular sciences, 26(9). : 4054-4054, 2025 | 김대중, 김혜진, 이관우, 이나미, 전자영, 최성이, 한승진, 허유정 |
| 2024 | | Acute Suppurative Thyroiditis as a Presentation of Disseminated Methicillin-Resistant Staphylococcus aureus Infection in an Adult with Type 1 Diabetes
Endocrinology and metabolism (Seoul, Korea), 39(4). : 664-668, 2024 | 이나미, 전자영, 최용준, 한승진 |
| 2024 | | Cysteine-rich 61 inhibition attenuates hepatic insulin resistance and improves lipid metabolism in high-fat diet fed mice and HepG2 cells
FASEB journal, 38(15). : e23859-e23859, 2024 | 김대중, 김혜진, 이관우, 이나미, 전자영, 최성이, 한승진, 허유정 |
| 2023 | | Amphiregulin Induces iNOS and COX-2 Expression through NF- κ B and MAPK Signaling in Hepatic Inflammation
Mediators of inflammation, 2023. : 2364121-2364121, 2023 | 강엽, 김대중, 김혜진, 이관우, 이나미, 전자영, 최성이, 한승진, 허유정 |
| 2022 | | Hepatoprotective effects of gemigliptin and empagliflozin in a murine model of diet-induced non-alcoholic fatty liver disease
Biochemical and biophysical research communications, 588. : 154-160, 2022 | 강엽, 김대중, 김혜진, 이관우, 이나미, 전자영, 최성이, 한승진, 허유정 |
| 2022 | | Characteristics and Clinical Course of Diabetes of the Exocrine Pancreas: A Nationwide Population-Based Cohort Study
Diabetes care, 45(5). : 1141-1150, 2022 | 김대중, 김혜진, 이관우, 이나미, 전자영, 한승진 |
| 2022 | | Empagliflozin Reduces the Progression of Hepatic Fibrosis in a Mouse Model and Inhibits the Activation of Hepatic Stellate Cells via the Hippo Signalling Pathway
Biomedicines, 10(5). : 1032-1032, 2022 | 강엽, 김대중, 김혜진, 이관우, 이나미, 전자영, 최성이, 한승진, 허유정 |
| 2022 | | The Degree of Glycemic Control for the First Three Months Determines the Next Seven Years
Journal of Korean medical science, 37(38). : e301-e301, 2022 | 김대중, 이나미 |
| 2021 | | Anti-inflammatory Effects of Empagliflozin and Gemigliptin on LPS-Stimulated Macrophage via the IKK/NF- κ B, MKK7/JNK, and JAK2/STAT1 Signalling Pathways
Journal of immunology research, 2021. : 9944880-9944880, 2021 | 강엽, 김대중, 김혜진, 이관우, 이나미, 전자영, 최성이, 한승진, 허유정 |
| 2021 | | Visfatin exacerbates hepatic inflammation and fibrosis in a methionine-choline-deficient diet mouse model
Journal of gastroenterology and hepatology, 36(9). : 2592-2600, 2021 | 강엽, 김대중, 김혜진, 이관우, 이나미, 전자영, 최성이, 한승진, 허유정 |
| 2021 | | Effectiveness and safety of sodium-glucose co-transporter-2 inhibitors compared with dipeptidyl peptidase-4 inhibitors in older adults with type 2 diabetes: A nationwide population-based study
Diabetes, obesity & metabolism, 23(3). : 682-691, 2021 | 김대중, 이나미, 하경화, 한승진 |
| 2020 | | CCL20 induced by visfatin in macrophages via the NF-kappaB and MKK3/6-p38 signaling pathways contributes to hepatic stellate cell activation
Molecular biology reports, 47(6). : 4285-4293, 2020 | 강엽, 김대중, 김혜진, 이관우, 이나미, 전자영, 최성이, 한승진 |
| 2020 | | Reduction of visceral fat could be related to the improvement of TBS in diabetes mellitus
Journal of bone and mineral metabolism, 38(5). : 702-709, 2020 | 이나미, 정윤석, 최용준 |
